Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Other Working Capital Changes (2016 - 2025)

Mesa Laboratories' Other Working Capital Changes history spans 16 years, with the latest figure at $244000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 70.42% year-over-year to $244000.0; the TTM value through Dec 2025 reached -$968000.0, up 88.92%, while the annual FY2025 figure was -$938000.0, 129.9% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was $244000.0 at Mesa Laboratories, up from -$813000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $9.0 million in Q4 2023 and bottomed at -$8.2 million in Q1 2024.
  • The 5-year median for Other Working Capital Changes is -$167500.0 (2024), against an average of -$52450.0.
  • The largest annual shift saw Other Working Capital Changes crashed 1113.7% in 2022 before it soared 1317.84% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $73000.0 in 2021, then plummeted by 1113.7% to -$740000.0 in 2022, then skyrocketed by 1317.84% to $9.0 million in 2023, then tumbled by 90.85% to $825000.0 in 2024, then plummeted by 70.42% to $244000.0 in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Other Working Capital Changes are $244000.0 (Q4 2025), -$813000.0 (Q3 2025), and $55000.0 (Q2 2025).